Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference

Conference Investment Track spotlights promising and emerging biotech and healthcare companies advancing the field of oncology SAN JOSE, Calif. , Jan. 29, 2024 /PRNewswire/ — Anixa Biosciences, Inc. (“Anixa” or the “Company”) (NASDAQ: ANIX), a clinical-stage biotechnology company focused…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks